No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply With NYSE American Listing Rules
Channel Therapeutics CHRO +50% Merges With Ligand LGND Subsidiaries; Adagio Medical ADGM +94% Breakthrough Device Designation
Sector Update: Health Care Stocks Softer Thursday Afternoon
Top Midday Gainers
Channel Therapeutics Shares Are Trading Higher After the Company Announced That It Will Combine With Ligand Subsidiary Pelthos Therapeutics to Create a Pain Medicines Focused Entity.
12 Health Care Stocks Moving In Thursday's Pre-Market Session